Mesmerizing Video Shows Cardiac Cells Building a Heart
The images were captured using a technique called light-sheet microscopy (LSM). Essentially, LSM involves scanning a sample with a thin sheet of light, creating sharp, detailed, three-dimensional images of living tissue without damaging it.
Researchers from University College London (UCL) and the Francis Crick Institute in the UK used the method to track how mouse embryo cells begin to specialize into roles, divide, and arrange themselves into the structure of a heart.
The team tagged the different types of cells with fluorescent markers, then captured images of them every two minutes for up to 41 hours. The resulting timelapse shows a ragtag group of nondescript cells coming together to form a living, beating mouse heart in a way that's truly captivating to watch.
It's not just beautiful; it helped the team uncover new details about cardiac development. Surprisingly, individual cells seemed to already 'know' where they need to go and which roles they'll end up playing, even as early as four or five hours after the first embryonic cell divided.
"Our findings demonstrate that cardiac fate determination and directional cell movement may be regulated much earlier in the embryo than current models suggest," says Kenzo Ivanovitch, developmental biologist at UCL.
"This fundamentally changes our understanding of cardiac development by showing that what appears to be chaotic cell migration is actually governed by hidden patterns that ensure proper heart formation."
While it's a long way off from any practical benefits, a better understanding of this process could potentially lead to new treatment options for congenital heart defects, the team says.
The research was published in The EMBO Journal.
Scientists Peered Inside The Echidna's Mysterious 'Pseudo-Pouch'
Bizarre Three-Eyed Predator Hunted The Ocean Half a Billion Years Ago
Earth's Rotation Is Slowing Down, And It Might Explain Why We Have Oxygen
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
9 hours ago
- Medscape
Is Your Personality Sabotaging Your Workout?
The hardest part of exercise may not be physical effort, but motivation. A new study published in Frontiers in Psychology suggests that aligning workouts with an individual's personality can significantly boost enjoyment and reduce stress, potentially improving long-term adherence. 'The most important part about exercising is finding something we enjoy and not being discouraged if we don't immediately find it.' 'It's ok if we don't enjoy a particular session,' said lead author Flaminia Ronca, PhD, professor of exercise physiology and neuroscience at the Institute of Sport, Exercise and Health, University College London, London, England. 'We can try something else,' said Ronca in a press release. Study Design This study included 132 healthy adults with a range of fitness levels. At baseline, participants underwent fitness tests to assess strength (eg, push-ups, plank hold, and jumping power) and endurance (person's ability to absorb oxygen during peak exertion on a cycle ergometer). Participants were divided into two groups: Intervention group: Completed an 8-week home-based cycling and strength training intervention. Control group: Participants maintained their usual daily routines. The participants also completed the surveys at baseline, during the first week, and after the intervention. Participants completed questionnaires in which they rated their enjoyment of the respective training sessions, stress levels (rated on a 1-10 scale), and personality using the established Big Five personality traits: extraversion, conscientiousness, agreeableness, neuroticism, and openness. The findings revealed clear connections between personality traits and preferred workout style. 'We found some clear connections between personality traits and the type of exercise participants enjoyed most,' Ronca said. 'I think this is important because this knowledge can potentially be used to tailor exercise recommendations more individually — and thus help people become and stay more active.' The analysis showed the following patterns linking personality traits and training preferences: Extroverted participants were mostly drawn to high-intensity sessions involving social interactions, such as team sports or high-intensity interval training. Participants high in neuroticism also responded well to high-intensity exercise but preferred shorter sessions with built-in breaks and valued privacy. They tended to avoid tracking performance metrics, such as heart rate. Those who were high in conscientiousness or openness to experience were the most consistent in completing the program, regardless of enjoyment. Their motivation stemmed from their health goals or intellectual curiosity. Stress Response Although both groups began the study with comparable stress levels, participants with high neuroticism in the intervention group showed a significant reduction in perceived stress by the end of the 8 weeks. 'It is fantastic news, as it highlights that those who benefit the most from a reduction in stress respond very well to exercise,' Ronca said. Key Takeaways Although all 86 participants who completed the training showed improved physical fitness, those who enjoyed the workouts were more likely to remain consistent. According to the researchers, these findings provide insights into how personality traits influence exercise-related behaviors, exercise enjoyment, long-term motivation, and stress management. These results demonstrate the potential utility of monitoring personality traits in future exercise studies and may aid in the design of training programs tailored to participants' needs. This story was translated from Medscape's German edition.
Newsweek
a day ago
- Newsweek
This Is the Age Range When Air Pollution Starts Damaging Your Brain
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Air pollution has long been linked to cardiovascular and respiratory illnesses, but new research suggests it may also significantly impair brain health—especially when exposure occurs during midlife. Researchers from University College London and King's College London published a study in The Lancet Healthy Longevity that identified the ages of 45 to 69 as a critical window during which air pollution is linked to cognitive decline and structurally damaging changes in the brain. Researchers followed participants in the study for nearly three decades, measuring exposure to pollutants like nitrogen dioxide and particulate matter, while assessing memory and processing speeds. They found that ambient air pollution can affect cognitive aging and increase dementia risk even before clinical symptoms emerge. Stock image of smoke billowing from three industrial chimneys. Stock image of smoke billowing from three industrial chimneys. Photo by Bilanol / Getty Images Why It Matters The global dementia burden is rising rapidly. Cases of the cognitive disease are projected to triple from 57 million to 153 million by 2050, according to the 2024 Lancet Commission, and identifying risk factors is crucial to slowing the trend. "Air pollution has been called the invisible killer and is the number one environmental threat to health in the world," study lead author Thomas Canning told Newsweek in an email. "The mortality burden of air pollution is not new—according to the chief medical officer's annual report in England, it is estimated to be between 26,000 and 38,000 premature deaths a year, but in addition to this, many people suffer avoidable chronic ill health. "This mortality has been linked to the effect of dirty air on the heart and lungs from cradle to death, but there is now an increasing body of evidence that suggests that air pollution isn't great for our brain either, with evidence suggested by our current and previous seminal research on these associations from the early developmental years now reaching up to later life." What To Know The study found that midlife exposure to nitrogen dioxide was associated with an 8.12-point decrease in processing speed on a 15-item recall task. Higher exposure levels also correlated with a 0.59-point reduction on the Addenbrooke's Cognitive Examination III, a standardized test for cognitive impairment. These effects remained noteworthy even after adjusting for childhood cognitive ability and earlier-life exposure, suggesting that midlife may be a uniquely vulnerable period for adults living with air pollution. "Childhood is a really pivotal time, but evidence prior to this study was also very clear about the risk to older adults due to the vulnerability of older age," Canning told Newsweek. "With the use of a novel 70-year follow-up period of people born in 1946, this study helped to clarify for the first time that exposure to air pollution in midlife was a risk to cognition and the brain in older age after taking into account a large number of lifelong socio-economic and clinical measures, as well taking into account exposure to air pollution from early childhood." What People Are Saying "It's really clear that air pollution at any exposure level is bad for many health problems—whether that's in children or adults," Canning told Newsweek. "Air pollution, like climate change, is not a problem to be entirely resolved or mitigated by scientists alone, but an issue deeply embedded into our individual and societal decisions and the power relations of our political systems. "Air pollution is a risk factor that is easily modifiable, and action can start at any level. There are many different ways that even local government can reduce it, and we know these changes work." What's Next Scientists in an accompanying Lancet commentary on the study noted, "Realistically, air pollution cannot be reduced by individual action but only through public health approaches." "Dementia-specific recommendations might include building/locating care homes away from busy roads, improving guidelines for healthcare professionals on considering the impact of the environment on their patients, and the development of behavioral interventions such as nature prescribing for dementia patients," Canning added.
Medscape
a day ago
- Medscape
Younger, Smaller Children Show Less Success With ART
Younger children living with HIV with low BMI for their age were more likely than older children to fail first-line antiretroviral therapy (ART), based on new data from the ODYSSEY trial presented at the International AIDS Society Conference on HIV Science. Although the ODYSSEY trial showed superior efficacy of dolutegravir (DTG)-based treatment than standard of care, data on predictors of treatment failure in children starting ART on DTG-based regimens are limited, wrote James Wyncoll, PhD, medical statistician at University College London, London, England, and colleagues in their abstract. The researchers reviewed data on 381 children who started first-line ART: 189 with DTG and 192 with standard of care. Most of the children (82%) were in Africa, 13% were in Thailand, and 5% were in Europe. At baseline, the median age of the children was 10.5 years, and the median CD4 percentage was 20%. The median BMI-for-age z-score was -0.58, and 19% of the participants met the World Health Organization (WHO) criteria for stage III/IV disease. The researchers considered the predictive values of baseline characteristics across four domains (anthropometrics, HIV indicators, hematology, and demographics) for treatment failure after 96 weeks. Overall, 75 children experienced treatment failure by 96 weeks, including 24 in the DTG group and 51 in the standard-of-care group. Fewer children treated with DTG experienced treatment failure and the risk declined with increasing age, the researchers wrote. However, predictors of treatment failure were not significantly different between treatment groups, they said. In the domain-specific models, after adjustment for weight and trial arm, independent and significant predictors of treatment failure included low BMI-for-age, low CD4%, WHO stage III/IV events, high neutrophils, and care at a location in Africa. In a multivariate analysis, DTG treatment, lower weight, CD4%, ongoing WHO stage III/IV events, and African region remained as significant predictors of treatment failure ( P < .1). Neutrophils were no longer significant after adjustment for ongoing WHO stage III/IV events, and BMI-for-age was no longer a significant predictor after adjustment for CD4% and region. 'The findings of this study can help clinicians by identifying characteristics at ART initiation which predict a child's risk of treatment failure,' Wyncoll told Medscape Medical News . This study provides information on predictors of treatment failure in children starting ART for the first time, including those starting DTG regimens, he said. Outside of clinical trials, adolescents receiving ART reportedly fared worse than younger children, but the current study showed that the risk for treatment failure declined with increasing age, Wyncoll said. 'We think it's likely that in trials, where participants have increased support, adolescents have good responses to treatment, and it is the youngest children who are at highest risk of treatment failure,' he noted. Reasons for greater treatment failure in younger children may include the need for different formulations, as well as the reliance on caregivers to administer the drugs, which can be difficult, he added. Both CD4% and BMI-for-age are previously recognized predictors of treatment failure. Takeaways and Next Steps The study's findings support previous research showing young age as a strong risk factor for treatment failure with ART, Wyncoll told Medscape Medical News. 'Even with early diagnosis and ART, other studies like the EARTH cohort and the LIFE trial show high mortality in the first 2 years of life, especially within the first 6 months,' he said. 'The EARTH study found that an adverse maternal social environment was linked to poorer outcomes and higher treatment failure in young children, emphasizing the need for strong, sustained support for mothers during pregnancy and early life of infants, including emotional and adherence support,' he noted. Screening for and preventing opportunistic infections such as tuberculosis and giving nutritional support is essential to promote treatment success, and baseline CD4 percentage can help identify children at highest risk for treatment failure, he said. The final model in the current study provides the basis for an online risk prediction tool for treatment failure, Wyncoll explained. Clinicians would enter a child's characteristics (such as treatment type, age, CD4%, and BMI for age) at ART initiation. 'Children are currently left behind when we consider novel treatment regimens,' Wyncoll said. 'Our work highlights the need for innovative approaches and more research into improved treatment for vulnerable children, such as different ART delivery methods or enhanced therapeutics,' he added. Although the researchers concluded that predictors of treatment failure for children in the DTG and SOC groups were the same, the findings were limited by the low rates of treatment failure for the children on DTG, Wyncoll told Medscape Medical News . 'Further research is needed using real-world data from children starting dolutegravir to consolidate these findings,' he said. Don't Discount DTG for Children Relatively few studies have examined risk factors for virologic failure in children with HIV, especially those on DTG, said Monica Gandhi, MD, director of the University of California San Francisco (UCSF) Bay Area Center for AIDS Research and professor of medicine at UCSF, in an interview. The current study findings showing a lower CD4 count when initiating ART or ongoing advanced HIV (as represented by the WHO stage III/IV events) or lower weight when starting ART were all risk factors for failure and were not unexpected, Gandhi told Medscape Medical News . 'What was surprising was to see DTG-based ART more associated with failure than standard-of-care (SoC) ART, since DTG is more potent and durable in adults,' she said. The clinical takeaway is to try to start ART in children as soon as possible to avoid low CD4 counts or more advanced HIV on ART, both of which are risk factors for failure, Gandhi said. DTG-based ART should still be the standard of care among children, but additional research is need to determine into what kind of formulations work best younger ages, such as a dispersible tablet for oral suspension, she added.
